Cardiovascular Health

Sexual minority populations disproportionately suffer from mental health conditions as well, which could partially impact cardiovascular health, a recent study indicates.

Devices that measure blood pressure in the upper arm would be the best choice for a more accurate and reliable reading.

Improving awareness and getting involved in local or national initiatives can enable pharmacists to make change.

Precision medicine is rooted in the reality that the way patients respond to treatment is heavily affected by their individual genetic variability, their complex biology, and external factors.

Since the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.

Diagnosing risk of frailty in patients hospitalized with heart failure is a safe and effective means of improving patient management.

Mendelian randomization makes it possible to infer if a drug target protein will have an on-target effect on disease-relevant traits.

Given the increasing value of patient satisfaction in determining the quality of care in the hospital reimbursement model, research is flourishing with a focus on identifying the factors that could positively influence patient satisfaction outcomes.

Less than 20% of physicians were open to starting a patient with nonvalvular atrial fibrillation on an anticoagulant after conducting a clinical review of the patient’s care.

The median change from baseline at week 24 in the 6-minute walk distance was 34.4 m in the sotatercept group and 1 m in the placebo group among patients with pulmonary arterial hypertension.

Lowering blood pressure could be dangerous for people with normal blood pressure.

Poor sleep efficiency may contribute to vascular dysfunction with increasing exposure to adverse childhood experiences.

Neurovascular mechanisms cause the decrease in BP levels, results from a study of 23 participants in Brazil show.

The findings could inform revisions to safety guidelines and policies that help protect people with cardiovascular issues during heat waves.

A new scientific statement from the American Heart Association notes that the process falls short for those who are not white.

Limiting added or free sugar is recommended to reduce the adverse effects, especially in cardiometabolic disease.

It is important for pharmacists to educate patients, especially those with cardiovascular risks, about the differences between fish oil supplements and prescription n3-FAs products.

Many long-term therapies rely solely on load amelioration, but new ones are needed, according to investigators.

Health benefits last for at least 5 years if shedding pounds occur via a lifestyle change program, the results of a research review show.

Transplant patients must adhere to lifelong regimens and those caring for them must consider their regimen as the patients intersect with different parts of the health care system.

Pharmacists respond to questions about supplementation and and smoking cessation for heart health.

Key lifestyle risk factors for chronic diseases and cancers include tobacco use, poor nutrition, lack of physical movement, and obesity.

Evinacumab-dgnb (Evkeeza; Regeneron Pharmaceuticals, Inc) is the first FDA-approved treatment indicated for children as young as 5 years of age to treat dangerously high levels of LDL-C.

Finerenone is a first in class nonsteroidal mineralocorticoid receptor antagonist indicated in adults with chronic kidney disease associated with type 2 diabetes mellitus.

At 1 year, patients receiving chemotherapy regimens containing anthracyclines for lymphoma who took statins had an average ejection fraction that was 1.3% higher than those who took placebo.